PCM
EHC icon

Prelude Capital Management’s Encompass Health EHC Stock Holding History

Prelude Capital Management’s Portfolio EHC Stock Details EHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-3,942
Closed -$418K – 1311
2025
Q4 		$418K Buy
+3,942
New +$457K 0.03% 617
2025
Q3 		– Sell
-1,805
Closed -$221K – 1213
2025
Q2 		$221K Buy
+1,805
New +$206K 0.02% 761
2025
Q1 		– Sell
-15,775
Closed -$1.46M – 1281
2024
Q4 		$1.46M Buy
+15,775
New +$1.55M 0.09% 265
2024
Q2 		– Sell
-10,146
Closed -$838K – 1293
2024
Q1 		$838K Sell
10,146
-3,864
-28% -$283K 0.04% 443
2023
Q4 		$935K Sell
14,010
-47
-0.3% -$3.04K 0.06% 314
2023
Q3 		$944K Sell
14,057
-11
-0.1% -$757 0.06% 315
2023
Q2 		$953K Sell
14,068
-1,094
-7% -$68.6K 0.06% 314
2023
Q1 		$820K Buy
15,162
+3,580
+31% +$208K 0.05% 346
2022
Q4 		$693K Sell
11,582
-7,361
-39% -$400K 0.04% 462
2022
Q3 		$857K Sell
18,943
-2,674
-12% -$134K 0.03% 463
2022
Q2 		$964K Buy
21,617
+9,518
+79% +$488K 0.03% 543
2022
Q1 		$684K Sell
12,099
-14,734
-55% -$769K 0.02% 726
2021
Q4 		$1.39M Buy
26,833
+4,406
+20% +$227K 0.04% 464
2021
Q3 		$1.34M Sell
22,427
-6,573
-23% -$414K 0.03% 445
2021
Q2 		$1.81M Buy
+29,000
New +$1.93M 0.05% 340
2019
Q3 		– Sell
-189
Closed -$10K – 1789
2019
Q2 		$10K Buy
+189
New +$9.17K ﹤0.01% 1389
2017
Q1 		– Sell
-2,987
Closed -$98K – 1567
2016
Q4 		$98K Buy
+2,987
New +$96.9K 0.01% 843
2014
Q1 		– Sell
-390
Closed -$10.2K – 1928
2013
Q4 		$10K Sell
390
-2,790
-88% -$77.6K ﹤0.01% 1506
2013
Q3 		$87K Sell
3,180
-581
-15% -$14.9K 0.01% 816
2013
Q2 		$86K Buy
+3,761
New +$85K 0.02% 720

Other funds holding EHC

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Prelude Capital Management's EHC Position: Q1 2026 in Review

Prelude Capital Management sold out of Encompass Health (EHC) in Q1 2026, closing a stake of 3,942 shares — an estimated $418K sold.

Prelude Capital Management first reported a position in EHC in Q2 2013 and held it in 20 quarters. The position peaked at $1.81M in Q2 2021. 577 funds tracked by Wall St. Rank hold EHC as of Q1 2026.

  • Prelude Capital Management reported no remaining Encompass Health position as of Q1 2026 after selling out during the quarter.
  • Prelude Capital Management sold 3,942 Encompass Health shares in Q1 2026, an estimated $418K.
  • Prelude Capital Management first reported a position in Encompass Health in Q2 2013 and held it in 20 quarters.
  • Prelude Capital Management's Encompass Health position peaked at $1.81M in Q2 2021.
  • 577 funds tracked by Wall St. Rank held Encompass Health as of Q1 2026.

Based on Prelude Capital Management's 13F filing for Q1 2026, filed 15 May 2026.